Saturday 17 October 2026 Export A’s income statement to Excel — free account

Agilent Technologies, Inc.

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%

Follow A

Alert me

Market cap: $49.5B
P/E: 34.0×
Fwd P/E: 26.3×
Dividend yield: 0.59%
F-score: 5/9
Altman Z: 5.46
Beneish M: −2.46
Dividend safety: 86/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total sells 3.17

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	3	1	—	—	—	—	1	—	—	—	1	—

Insider Ownership 0.36%

Capital & Financial Ratios $m

Market Cap 49,490.00

Revenue 7,372.00

Net Income 1,440.00

Free Cash Flow 1,267.00

Net Debt 1,887.00

Current Ratio 2.05

Debt/Equity 0.50

P/E ratio 33.98

Fwd P/E 26.30

P/S ratio 6.62

P/B ratio 6.62

Past 5Y EPS Growth 14.72%

This Y EPS Growth 10.95%

Next Y EPS Growth 8.72%

Next Y revenue growth 7.94%

Next 5Y EPS Growth 10.02%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 66.13%

10-year low 10-year high

P/S against its own 10 years 87.36%

10-year low 10-year high

P/B against its own 10 years 70.07%

10-year low 10-year high

EV/Sales against its own 10 years 88.09%

10-year low 10-year high

EV/FCF against its own 10 years 85.88%

10-year low 10-year high

Dividends

Payout Ratio 0.20

Annual Dividend Rate 1.02

Annual Dividend Yield 0.59%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	1.02	0.26 0.26 0.26 0.26
2025	0.98	0.25 0.25 0.25
2024	0.96	0.24 0.24 0.24 0.25
2023	0.91	0.23 0.23 0.23 0.24
2022	1.07	0.21 0.21 0.21 0.21 0.23
2021	0.78	0.19 0.19 0.19 0.19
2020	0.54	0.18 0.18 0.18
2019	0.67	0.16 0.16 0.16 0.18
2018	0.61	0.15 0.15 0.15 0.16
2017	0.55	0.13 0.13 0.13 0.15
2016	0.48	0.12 0.12 0.12 0.13

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	1,590	1,329	1,789	1,758
Receivables	1,291	1,324	1,487	1,478
Inventory	1,031	972	1,025	1,117
Other	274	334	293	340
	4,186	3,959	4,594	4,693

	2023	2024	2025	Q'26
Payables	418	540	570	608
ST’ Debt	—	—	—	—
Other	—	—	—	—
	1,603	1,895	2,347	2,289

Compound Annual Growth %

	10y	5y	3y
Sales	5.58%	5.41%	0.48%
Cash Flow	11.78%	11.10%	5.92%
Earnings	12.51%	12.63%	1.29%
Book Value	4.92%	6.71%	8.31%

Revenue $m

	Jan	Apr	Jul	Oct	Year
’26	1,798	1,835	1,878	—	—
’25	1,681	1,668	1,738	1,861	6,948
’24	1,658	1,573	1,578	1,701	6,510
’23	1,756	1,717	1,672	1,688	6,833
’22	1,674	1,607	1,718	1,849	6,848
’21	1,548	1,525	1,586	1,660	6,319
’20	1,357	1,238	1,261	1,483	5,339

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Jan	Apr	Jul	Oct	Year
’26	268	277	519	—	—
’25	431	221	362	545	1,559
’24	485	333	452	481	1,751
’23	296	398	562	516	1,772
’22	255	283	326	448	1,312
’21	238	472	334	441	1,485
’20	(59)	313	290	377	921

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Jan	Apr	Jul	Oct	Year
’26	175	201	439	—	—
’25	338	107	259	452	1,152
’24	395	230	360	388	1,373
’23	220	341	481	432	1,474
’22	180	219	244	378	1,021
’21	197	441	279	379	1,297
’20	(93)	280	266	350	803

Fiscal quarters ending in the months shown.

EPS $

	Jan	Apr	Jul	Oct	Year
’26	1.07	1.20	1.28	—	—
’25	1.11	0.75	1.18	1.53	4.57
’24	1.18	1.05	0.97	1.22	4.43
’23	1.19	1.02	0.38	1.62	4.19
’22	0.93	0.91	1.10	1.23	4.18
’21	0.93	0.70	0.86	1.45	3.94
’20	0.63	0.32	0.64	0.71	2.30

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	34.15	45.74	60.42	62.00	61.13	112.47	112.52	96.80	124.16	96.43	Analyst estimates 2026–2028 Powerpack
	High	48.63	70.93	75.11	85.68	120.24	179.57	160.26	159.59	155.35	160.27
People
People	Employees	12,500	13,500	14,800	16,300	16,400	17,000	18,100	18,100	17,900	18,100
	Revenue/emp, $m	0.34	0.33	0.33	0.32	0.33	0.37	0.38	0.38	0.36	0.38
Income, $m
Income, $m	Revenue	4,202	4,472	4,914	5,163	5,339	6,319	6,848	6,833	6,510	6,948
	Gross margin, %	52.28	53.64	54.54	54.33	53.14	53.92	54.35	50.71	54.30	52.43
	EBT	544	803	946	919	842	1,360	1,504	1,339	1,521	1,435
	EBT margin, %	12.95	17.96	19.25	17.80	15.77	21.52	21.96	19.60	23.36	20.65
	Net income	462	684	316	1,071	719	1,210	1,254	1,240	1,289	1,303
	Depreciation	246	212	210	238	308	321	317	271	257	288
Per share, $
Per share, $	Revenue	12.89	13.89	15.31	16.44	17.28	20.79	22.90	23.24	22.45	24.46
	Earnings	1.41	2.12	0.98	3.41	2.33	3.98	4.19	4.22	4.44	4.59
	Cash flow	2.43	2.76	3.39	3.25	2.98	4.88	4.39	6.03	6.04	5.49
	Capex	(0.43)	(0.55)	(0.55)	(0.50)	(0.38)	(0.62)	(0.97)	(1.01)	(1.30)	(1.43)
	Free cash flow	2.01	2.21	2.84	2.75	2.60	4.27	3.41	5.01	4.73	4.06
	Book value	13.02	15.02	14.24	15.12	15.77	17.73	17.74	19.88	20.34	23.74
	Shares, m	326	322	321	314	309	304	299	294	290	284
Valuation, ×
Valuation, ×	P/E	30.90	31.94	64.79	22.35	45.17	39.46	32.94	24.50	29.35	31.96
	P/S	3.38	4.90	4.23	4.61	6.09	7.56	6.04	4.45	5.80	5.98
	P/B	3.35	4.53	4.55	5.01	6.67	8.86	7.80	5.20	6.41	6.17
	EV/Sales	3.29	4.70	4.14	4.69	6.25	7.74	6.29	4.62	6.11	6.16
	EV/FCF	21.13	29.49	22.34	27.94	41.55	37.76	42.29	21.44	29.06	37.11
Cash, $m
Cash, $m	Operating cash flow	793	889	1,087	1,021	921	1,485	1,312	1,772	1,751	1,559
	Capex	(139)	(176)	(176)	(156)	(118)	(188)	(291)	(298)	(378)	(407)
	Free cash flow	654	713	911	865	803	1,297	1,021	1,474	1,373	1,152
Balance, $m
Balance, $m	Working capital	2,690	2,906	2,677	1,109	1,948	2,091	1,917	2,583	2,064	2,247
	Total debt	1,904	1,801	1,799	1,791	2,284	2,729	2,733	2,735	3,345	3,050
	Net debt	(385)	(877)	(448)	409	843	1,154	1,680	1,145	2,016	1,261
	Shareholders’ equity	4,246	4,835	4,571	4,748	4,873	5,389	5,305	5,845	5,898	6,741
Returns, %
Returns, %	ROA	6.05	8.43	3.72	11.90	7.54	11.90	11.81	11.65	11.40	10.61
	ROIC	9.96	12.74	13.70	11.40	9.25	12.87	14.48	12.07	11.75	11.55
	ROE	10.98	15.06	6.72	22.99	14.95	23.58	23.45	22.24	21.95	20.62

Negative figures in brackets.

All 10 years →

Fiscal years to Oct 2025 · latest quarter Jul 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
NTRA Natera, Inc.	$58.4B	— (loss-making)	— (loss-making)	+37.71% (above 0%: growing)	n/m	−173.96% (below 0%: shrinking)	64.46%	(10.07%)	Compare
A Agilent Technologies, Inc.	$49.5B	34.0×	26.3×	+8.06% (above 0%: growing)	+8.47% (above 0%: growing)	+69.50% (above 0%: growing)	55.48%	23.64%
IQV IQVIA Holdings Inc.	$44.6B	32.8×	22.3×	+8.74% (above 0%: growing)	−0.65% (below 0%: shrinking)	+23.29% (above 0%: growing)	32.85%	11.58%	Compare
WAT Waters Corporation	$43.6B	109×	44.3×	+113.36% (above 0%: growing)	n/m	+750.00% (above 0%: growing)	44.62%	(5.23%)	Compare
IDXX IDEXX Laboratories, Inc.	$43.1B	39.1×	38.3×	+9.66% (above 0%: growing)	+17.21% (above 0%: growing)	+111.44% (above 0%: growing)	64.04%	34.98%	Compare
ILMN Illumina, Inc.	$40.5B	48.4×	34.7×	+9.44% (above 0%: growing)	−8.05% (below 0%: shrinking)	−18.27% (below 0%: shrinking)	66.44%	21.14%	Compare
MTD Mettler-Toledo International, Inc.	$32.8B	36.4×	25.5×	+4.48% (above 0%: growing)	+18.30% (above 0%: growing)	+33.01% (above 0%: growing)	63.29%	30.61%	Compare
DGX Quest Diagnostics Incorporated	$26.4B	24.6×	20.8×	+10.21% (above 0%: growing)	+14.74% (above 0%: growing)	+5.28% (above 0%: growing)	33.75%	15.08%	Compare
LH Labcorp Holdings Inc.	$26.4B	26.2×	19.0×	+5.78% (above 0%: growing)	+28.42% (above 0%: growing)	−42.01% (below 0%: shrinking)	29.80%	12.10%	Compare
Median of peers	$41.8B	36.4×	25.5×	+9.55%	+15.98%	+14.29%	53.96%	13.59%

All 52 Diagnostics & Research stocks →

Agilent Technologies, Inc. (A) key facts

Strength: Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024.
Strength: Net income was $1.3 billion, or $4.59 per share (basic), a net margin of 18.8%.
Agilent Technologies, Inc. (A) is a Diagnostics & Research company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, A traded at $172.96, a market capitalization of $49.5 billion.
At that price the stock trades at 34.0× trailing-twelve-month earnings and 6.6× sales; its P/E is higher than 66% of its own readings over the past ten years.
Agilent Technologies, Inc. pays an annual dividend of $1.02 per share, a yield of 0.59%, with a payout ratio of 20.1%.
Return on equity was 20.6% and debt-to-equity 0.50.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 5.46 (safe zone) for fiscal 2025.